课题基金 / 基金详情

Lysosome Regulation and Signaling in Aging and Alzheimer's Disease

Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
衰老和阿尔茨海默病中的溶酶体调节和信号传导
批准号:
10655043
负责人:
Hui Zheng
金额:
$25.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-01 至 2023-02-28

项目摘要

项目成果

Hui Zheng的其他基金

相关文献

中文摘要
翻译
这是一项计划项目拨款的设备补充申请(P01AG066606,6月 2021年2月1日-2026年2月28日,PI:郑惠)。家长P01的首要目标是 溶酶体到核信号通路调节溶酶体内稳态的研究 衰老和阿尔茨海默氏症。P01由三个高度互动的项目和两个 科学核心,由管理和数据集成核心监督。其中一个 P01的基本成分是核心C:溶酶体代谢组学和pH。核心用途 基于高通量质谱仪的代谢组学评估溶酶体的变化 衰老和肌萎缩侧索硬化症中的代谢活动。核心C领导人王蒙是哈佛大学教授 贝勒医学院和霍华德·休斯医学研究所(HHMI)的研究员。 她拥有一台用于溶酶体的Thermo Orbitrap Fusion Lumos三元质谱仪 代谢组学实验。最近,王医生决定离开贝勒,开始一份新的工作 HHMI Janelia研究园区的职位,2022年8月1日生效。珍妮莉亚组织 是由HHMI独家支持的,因此,王博士不再能够参与 PPG。此外,由于王博士使用HHMI基金购买了质谱仪,她将需要 把乐器带到她的新岗位上。我们已经确认了冯笠博士,副教授在 贝勒学院药物发现中心和病理与免疫学系 药物和LC-MS代谢组学方面的专家,取代王博士成为Core C的领导者。 我们已经与保罗·巴雷特博士讨论了这一变化和质谱分析的必要性,他是 P01,谁支持设备补充申请购买保温器 Science™Orbitrap Exploris120LC/MS系统进行溶酶体特异性代谢研究 如家长P01所建议的概况分析。
英文摘要
This is an equipment supplement application for a Program Project Grant (P01AG066606, June 1, 2021-February 28, 2026, PI: Zheng, Hui). The overarching goal of the parent P01 is to investigate the lysosome-to-nucleus signaling pathways regulating lysosomal homoeostasis in aging and Alzheimer’s disease. The P01 consists of three highly interactive projects and two scientific cores, which are overseen by an administration and data integration core. One of the essential components of the P01 is Core C: Lysosomal Metabolomics and pH. The Core uses high-throughput Mass Spectrometer-based metabolomics to assess changes in lysosomal metabolic activity in aging and tauopathy. The Core C Leader, Meng Wang, is a Professor at Baylor College of Medicine and an Investigator of the Howard Hughes Medical Institute (HHMI). She owns a Thermo Orbitrap Fusion Lumos Tribrid Mass Spectrometer for the lysosomal metabolomics experiments. Recently Dr. Wang has decided to leave Baylor and take on a new position at HHMI Janelia Research Campus, effective August 1, 2022. The Janelia organization is exclusively supported by HHMI and, as a result, Dr. Wang is no longer able to participate in the PPG. In addition, since Dr. Wang purchased mass spec using the HHMI funds, she will need to take the instrument to her new post. We have identified Dr. Feng Li, Associate Professor in the Center for Drug Discovery and the Department of Pathology & Immunology at Baylor College of Medicine and an expert in LC-MS metabolomics, to replace Dr. Wang as the leader for Core C. We have discussed this change and the need for a mass spec with Dr. Paul Barrett, the PO of the P01, who is supportive of the equipment supplement application to purchase a Thermo Scientific™ Orbitrap Exploris 120 LC/MS system to perform lysosome-specific metabolomic profiling as proposed in the parent P01.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A TFEB and V-ATPase-mediated lysosomal stress sensing pathway in tauopathy
  • 批准号:
    10413975
  • 项目类别:
  • 资助金额:
    $51.31万
  • 财政年份:
    2021
  • 负责人:
    Hui Zheng
  • 依托单位:
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
  • 批准号:
    10172231
  • 项目类别:
  • 资助金额:
    $263.3万
  • 财政年份:
    2021
  • 负责人:
    Hui Zheng
  • 依托单位:
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
  • 批准号:
    10413970
  • 项目类别:
  • 资助金额:
    $260.8万
  • 财政年份:
    2021
  • 负责人:
    Hui Zheng
  • 依托单位:
Administration and Data Integration Core
  • 批准号:
    10583536
  • 项目类别:
  • 资助金额:
    $24.08万
  • 财政年份:
    2021
  • 负责人:
    Hui Zheng
  • 依托单位: